Allianz Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Allianz Asset Management's TNDM Position: Q2 2026 in Review
Allianz Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 16,900 shares — an estimated $324K sold.
Allianz Asset Management first reported a position in TNDM in Q3 2018 and held it in 21 quarters. The position peaked at $39.6M in Q2 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Allianz Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
- Allianz Asset Management sold 16,900 Tandem Diabetes Care shares in Q2 2026, an estimated $324K.
- Allianz Asset Management first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 21 quarters.
- Allianz Asset Management's Tandem Diabetes Care position peaked at $39.6M in Q2 2020.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.